This federal contract award is for the delivery of RINVOQ ER 15 MG TABLET UU 30S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract, valued at $35,250.60, is a Firm Fixed Price Delivery Order with an ultimate completion date of October 18, 2024. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. This award is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA, valued at $999,999,999 and running through November 2026. The IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition.
Generated 1/16/25, 9:35 AM